Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification: a Prospective Multicenter Umbrella Clinical Study（FEMUS）

NCT07319429 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07319429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07319429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification: a Prospective Multicenter Umbrella Clinical Study（FEMUS）
Lead sponsor
Fudan University
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 25, 2026
Completion date
December 31, 2029
Enrollment
260 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, fertility